Buyao Li

机构：Peking University

发表论文 7 篇 · 总被引 118 次 · h-index 4

代表论文

• RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment (2024 · Nature Communications · 被引 43)
• Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging (2025 · Cell Reports Medicine · 被引 42)
• Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury (2025 · Nature Communications · 被引 28)
• Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in-vivo CAR-T therapy for inflamm-aging (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)
• Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING (2026 · Nature Biotechnology)
• Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury (2025 · Carolina Digital Repository (University of North Carolina at Chapel Hill))